SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Olsson M) srt2:(2020-2024)"

Sökning: WFRF:(Olsson M) > (2020-2024)

  • Resultat 1-10 av 637
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  • Mullins, N., et al. (författare)
  • Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
  • 2021
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 53, s. 817-829
  • Tidskriftsartikel (refereegranskat)abstract
    • Bipolar disorder is a heritable mental illness with complex etiology. We performed a genome-wide association study of 41,917 bipolar disorder cases and 371,549 controls of European ancestry, which identified 64 associated genomic loci. Bipolar disorder risk alleles were enriched in genes in synaptic signaling pathways and brain-expressed genes, particularly those with high specificity of expression in neurons of the prefrontal cortex and hippocampus. Significant signal enrichment was found in genes encoding targets of antipsychotics, calcium channel blockers, antiepileptics and anesthetics. Integrating expression quantitative trait locus data implicated 15 genes robustly linked to bipolar disorder via gene expression, encoding druggable targets such as HTR6, MCHR1, DCLK3 and FURIN. Analyses of bipolar disorder subtypes indicated high but imperfect genetic correlation between bipolar disorder type I and II and identified additional associated loci. Together, these results advance our understanding of the biological etiology of bipolar disorder, identify novel therapeutic leads and prioritize genes for functional follow-up studies. Genome-wide association analyses of 41,917 bipolar disorder cases and 371,549 controls of European ancestry provide new insights into the etiology of this disorder and identify novel therapeutic leads and potential opportunities for drug repurposing.
  •  
4.
  • Axfors, Cathrine, et al. (författare)
  • Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials
  • 2021
  • Ingår i: BMC Infectious Diseases. - : BioMed Central (BMC). - 1471-2334. ; 21:1
  • Forskningsöversikt (refereegranskat)abstract
    • Background: Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, ). Methods: In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung-Knapp-Sidik-Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results: A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I-2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions: Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 637
Typ av publikation
tidskriftsartikel (490)
konferensbidrag (119)
forskningsöversikt (8)
rapport (7)
bokkapitel (7)
doktorsavhandling (3)
visa fler...
bok (2)
samlingsverk (redaktörskap) (1)
visa färre...
Typ av innehåll
refereegranskat (470)
övrigt vetenskapligt/konstnärligt (165)
populärvet., debatt m.m. (2)
Författare/redaktör
Olsson, T (114)
Piehl, F (67)
Hillert, J (56)
Lycke, J (46)
Kockum, I. (44)
Svenningsson, A (40)
visa fler...
Burman, J. (39)
Nilsson, P. (38)
Martin, C (34)
Dahle, C. (34)
Forsberg, L. (34)
Olsson, Richard (33)
Olsson, M. (30)
Olsson, A (30)
Olsson, H. (28)
Khademi, M. (26)
Olsson, Håkan (25)
Seo, Sachiko (24)
Gunnarsson, M (23)
Olsson, Tina M. (22)
Lazarus, Hillard M (22)
Nishihori, Taiga (22)
Gunnarsson, Martin, ... (20)
Hopper, JL (19)
Easton, DF (19)
Olsson, C (19)
Olsson, Tina M., 197 ... (19)
Savani, Bipin N (19)
Jagodic, M (18)
Olsson, Urban, 1954 (18)
Wolk, Alicja (18)
Pharoah, PDP (18)
Saber, Wael (18)
Aljurf, Mahmoud (18)
Milne, RL (17)
Chang-Claude, J (17)
Haiman, CA (17)
Jakubowska, A (17)
Chhabra, Saurabh (17)
John, EM (17)
Skoog, Therése (17)
Giles, GG (16)
Alfredsson, L (16)
Southey, MC (16)
Dunning, AM (16)
Andrulis, IL (16)
Fasching, PA (16)
Cerny, Jan (16)
Kharfan-Dabaja, Moha ... (16)
Schmutzler, RK (16)
visa färre...
Lärosäte
Karolinska Institutet (327)
Göteborgs universitet (152)
Uppsala universitet (112)
Lunds universitet (105)
Jönköping University (38)
Kungliga Tekniska Högskolan (36)
visa fler...
Örebro universitet (34)
Chalmers tekniska högskola (31)
Linköpings universitet (27)
Stockholms universitet (26)
Umeå universitet (25)
Högskolan i Halmstad (17)
Högskolan Väst (12)
Mittuniversitetet (12)
Sveriges Lantbruksuniversitet (11)
Karlstads universitet (8)
Malmö universitet (6)
Högskolan i Gävle (5)
Naturhistoriska riksmuseet (5)
Högskolan Kristianstad (4)
Linnéuniversitetet (4)
Marie Cederschiöld högskola (4)
RISE (3)
Luleå tekniska universitet (2)
Mälardalens universitet (2)
Handelshögskolan i Stockholm (2)
Högskolan i Borås (2)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (619)
Svenska (17)
Norska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (287)
Naturvetenskap (103)
Samhällsvetenskap (70)
Teknik (38)
Lantbruksvetenskap (11)
Humaniora (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy